Top news of the week: 13.05.2022.
Career And Jobs
Amid Waves of Biotech Layoffs, ADC Developers like ImmunoGen are Thriving
ImmunoGen, which is developing Antibody-drug conjugates (ADCs) for the treatment of cancer, is on a hiring spree. The company is looking to hire for more than 200 positions by the end of ...
How to Navigate a Career Change From Biotech To Pharma
BioSpace spoke with industry experts to find out the differences between working in pharma and biotech and how to know if a pharma company is right for you.
Exclusive: Novo Nordisk allies itself with one of the buzziest groups in biotech, launching a multi-pronged attack at discovering new drugs
Novo Nordisk established its R&D rep around its in-house expertise that ultimately birthed the GLP-1 blockbuster semaglutide and pushed it to major-market franchise status. But its top ...
DEI Leadership Training Package for Biotech Startups (with 12+ employees)
It's time to do the work to instill Diversity, Equity, & Inclusion (DEI) into your growing organization. Join us!
Scoop: ExeVir hits pause on llama-derived Covid antibody amid Omicron variants, shifts focus to second-gen work
ExeVir has returned to the drawing board after pausing work on its first-generation llama-derived Covid-19 antibody and is turning its R&D focus toward a preclinical second-gen attempt, ...
Moderna's new CFO out after former employer unveils internal auditing investigation
Just as quickly as he started, the new CFO at Moderna has been shown the door after a single day on the job. Jorge Gomez was out in a day after his former employer, Dentsply Sirona, said it ...
Exclusive: Aspen Neuroscience collects large Series B to compete against Bayer's Parkinson's cell therapy
Damien McDevitt thinks frequently about the name Aspen Neuroscience. Specifically, should the neuroscience portion be dropped as the San Diego biotech considers expanding beyond the CNS? ...
BigHat Biosciences Appoints Rob Chess, Serial Entrepreneur, to its Board of Directors
SAN MATEO, Calif.--(BUSINESS WIRE)--BigHat Biosciences, a biotechnology company designing safer, more effective next-generation antibody therapies for patients using machine learning and ...